GAMMA Investing »

Silence Therapeutics shares owned by GAMMA Investing

Quarter-by-quarter ownership of Silence Therapeutics (SLN) shares owned by GAMMA Investing from 13F filings

Historical chart of GAMMA Investing investment in Silence Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silence Therapeutics held by GAMMA Investing consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silence Therapeutics by GAMMA Investing

Quarter filed Position value Share count Share price at filing
2024-03-31 $19k 876 21.60
2023-12-31 $21k 918 22.51

More positions owned by GAMMA Investing

Microsoft Corp Common Stock (MSFT)
Nvidia Corporation Common Stock (NVDA)
Apple Common Stock (AAPL)
Amazon Common Stock (AMZN)
Jpmorgan Chase Common Stock (JPM)
Meta Platforms Inc Cl A Common Stock (META)
Alphabet Inc Cap Stk Cl A Common Stock (GOOGL)
Ishares Tr National Mun Etf Etf (MUB)
Visa Inc Com Cl A Common Stock (V)
Broadcom Common Stock (AVGO)
Alphabet Inc Cap Stk Cl C Common Stock (GOOG)
Ishares Inc Core Msci Emkt Etf (IEMG)
Eli Lilly Common Stock (LLY)
Home Depot Common Stock (HD)
Berkshire Hathaway Inc Del Cl B Common Stock (BRK.B)

View all positions for GAMMA Investing

Top funds holding Silence Therapeutics

Artal Group
Lombard Odier Asset Management
Lombard Odier Asset Management
Redmile Group
Logos Global Management
Frazier Life Sciences Management
Vivo Capital
Nextech Invest
Henderson Group
Cormorant Asset Management
Adage Capital Partners GP
Aquilo Capital Management
Lynx1 Capital Management
5AM Venture Management
Millennium Management

View all funds holding Silence Therapeutics